Sec. 3. Modification of rules of origin for pharmaceutical products
166 words·~1 min read·
/bill/116/s/3538/is/section-3A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 308(4)(B) of the Trade Agreements Act of 1979 ( 19 U.S.C. 2518(4)(B) ) is amended— in clause (i), by striking instrumentality, or and inserting instrumentality, ; in clause (ii)— by inserting , other than an active pharmaceutical ingredient, after part of materials ; and by striking the period at the end and inserting , or ; and by inserting before the period at the end the following:
(iii)in the case of an article which consists of an active pharmaceutical ingredient, the pharmaceutical ingredient is wholly the growth, product, or manufacture of that country or instrumentality . Not later than 180 days after the date of the enactment of this Act, the President shall prescribe regulations to update sections 52.225–5 and 25.003 of title 48, Code of Federal Regulations (or successor regulations) to be consistent with rules of origin determinations for active pharmaceutical ingredients made under section 308(4)(B) of the Trade Agreements Act of 1979 ( 19 U.S.C. 2518(4)(B) ), as amended by subsection (a).
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 3
Modification of rules of origin for pharmaceutical products
Cites 1Cited by 0 across 0 sources